FDA gives full approval to a drug designed to slow Alzheimer's disease

[ad_1]
FDA gives full approval to a drug designed to slow Alzheimer's disease - CBS News

Watch CBS News

The Food and Drug Administration on Thursday gave its approval to Leqembi, a drug designed to slow the progression of Alzheimer's disease. Leqembi is not considered a cure for Alzheimer’s, but will be covered by Medicare. Dr. Jon LaPook has more.

Be the first to know

Get browser notifications for breaking news, live events, and exclusive reporting.

[ad_2] Source link https://worldnews2023.com/health/fda-gives-full-approval-to-a-drug-designed-to-slow-alzheimers-disease/?feed_id=22351&_unique_id=64a758f4376ea

Comments

Popular posts from this blog

SBP raises key interest rate to 25-year high of 17%

Finance secretary summoned by ECP over non-provision of election funds

Real Housewives of Beverly Hills couple Kyle Richards and Mauricio Umansky ‘seperate’